rs397508511
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM1PP2
The NM_000492.4(CFTR):c.3169A>G(p.Thr1057Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000167 in 1,612,458 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1057I) has been classified as Uncertain significance.
Frequency
Consequence
NM_000492.4 missense
Scores
Clinical Significance
Conservation
Publications
- cystic fibrosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet
- congenital bilateral absence of vas deferensInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary chronic pancreatitisInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CFTR | NM_000492.4 | c.3169A>G | p.Thr1057Ala | missense_variant | Exon 20 of 27 | ENST00000003084.11 | NP_000483.3 | |
| CFTR-AS2 | NR_199597.1 | n.177+4619T>C | intron_variant | Intron 2 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152136Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000319 AC: 8AN: 250640 AF XY: 0.0000443 show subpopulations
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1460322Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 726528 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152136Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74318 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cystic fibrosis Uncertain:5
This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 1057 of the CFTR protein (p.Thr1057Ala). This variant is present in population databases (rs397508511, gnomAD 0.01%). This missense change has been observed in individual(s) with mild clinical features of cystic fibrosis (PMID: 23670503, 32819855). ClinVar contains an entry for this variant (Variation ID: 53668). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CFTR protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
The p.T1057A variant (also known as c.3169A>G), located in coding exon 20 of the CFTR gene, results from an A to G substitution at nucleotide position 3169. The threonine at codon 1057 is replaced by alanine, an amino acid with similar properties. This variant was reported in an individual with suspected mild or atypical cystic fibrosis; no second variant was detected in the individual and clinical information was not provided (Dal'Maso VB et al, J Bras Pneumol; 39(2):181-9). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
- -
not provided Uncertain:3
- -
- -
- -
not specified Uncertain:1
Variant summary: CFTR c.3169A>G (p.Thr1057Ala) results in a non-conservative amino acid change located in the ABC transporter type 1, transmembrane domain (IPR011527) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.2e-05 in 250640 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.3169A>G has been reported in the literature in individuals affected with Cystic Fibrosis (DalMaso_2013, Rispoli_2020, da Silva_2020, Bozdogan_2021). These reports do not provide unequivocal conclusions about association of the variant with Cystic Fibrosis. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 16311287, 11504857, 23670503, 25735457, 32819855, 32185651, 33572515). ClinVar contains an entry for this variant (Variation ID: 53668). Based on the evidence outlined above, the variant was classified as uncertain significance. -
CFTR-related disorder Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at